QLC5508

· Qilu Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for QLC5508, covering 2025-09-30 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: QLC5508 vs. Chemotherapy in Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma [Phase 3]